Clinical Trial Update: Rule of Carbone Monoxyde in the Ex Vivo Lung Perfusion Reconditionning [NA]

View source ↗

Summary

This clinical trial update describes evaluating carbon monoxide during ex vivo lung perfusion reconditioning for neurogenic pulmonary edema; the current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Pulmonary Edema

Drugs mentioned

• Carbon Monoxide (carbon monoxide)

Snippet

Sponsor: University Hospital of Mont-Godinne | Conditions: Neurogenic Lung Edema | NA | Status: UNKNOWN